Loading
SC
Spectranetics Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Drake Scott William, was filed 09 Nov 2015.
Spectranetics Corp: what insiders have been doing
Spectranetics Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Spectranetics Corp has published a filing in the past twelve months. The most recent one dates from 11 August 2017.
The full history, which starts in 2006, counts 59 purchases against 55 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
429
Thresholds
n/a
Buy Volume
€3M
59 ops. · all time
Sell Volume
€12M
55 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
RevenueUS$241.4M
Gross profitUS$180.5M75% margin
Net income-US$51.8M-21.5% margin
Last declaration on 11 August 2017
Declarations429 total
72,966 shares@ US$38.5083.6% of flowSPNC Common StockSEC:0001179110-17-011358:0
69,493 shares@ US$38.50100.0% of flowSPNC Common StockSEC:0001179110-17-011361:0
17,411 shares@ US$38.5070.3% of flowSPNC Common StockSEC:0001179110-17-011368:0
133,839 shares@ US$38.5075.9% of flowSPNC Common StockSEC:0001179110-17-011365:0
83,412 shares@ US$38.50100.0% of flowSPNC Common StockSEC:0001179110-17-011359:0
141,697 shares@ US$38.50100.0% of flowSPNC Common StockSEC:0001179110-17-011362:0
31,219 shares@ US$38.50100.0% of flowSPNC Common StockSEC:0001179110-17-011360:0
34,276 shares@ US$38.50100.0% of flowSPNC Common StockSEC:0001179110-17-011356:0
25,251 shares@ US$38.5081.4% of flowSPNC Common StockSEC:0001179110-17-011364:0
269,027 shares@ US$38.5080.8% of flowSPNC Common StockSEC:0001179110-17-011367:0
15,548 shares@ US$38.50100.0% of flowSPNC Common StockSEC:0001179110-17-011355:0
241 shares@ US$38.350.8% of flowSPNC Common StockSEC:0000789132-17-000121:1
4,601 shares@ US$38.351.4% of flowSPNC Common StockSEC:0000789132-17-000119:1
1,104 shares@ US$38.350.6% of flowSPNC Common StockSEC:0000789132-17-000120:1
754 shares0SPNC Common StockSEC:0000789132-17-000121:0
9,879 shares0SPNC Common StockSEC:0000789132-17-000119:0
2,372 shares0SPNC Common StockSEC:0000789132-17-000120:0
4,005 shares@ US$30.901.0% of flowSPNC Common StockSEC:0000789132-17-000113:1
755 shares@ US$30.900.4% of flowSPNC Common StockSEC:0000789132-17-000114:1
272 shares@ US$30.900.7% of flowSPNC Common StockSEC:0000789132-17-000115:1
8,600 shares0SPNC Common StockSEC:0000789132-17-000113:0
1,622 shares0SPNC Common StockSEC:0000789132-17-000114:0
853 shares0SPNC Common StockSEC:0000789132-17-000115:0
1,964 shares@ US$26.350.8% of flowSPNC Common StockSEC:0000789132-17-000103:1
3,275 shares@ US$26.350.7% of flowSPNC Common StockSEC:0000789132-17-000101:1
25 of 429 declarations
About Spectranetics Corp
Spectranetics Corp is a company focused on developing medical technologies for the treatment of cardiovascular diseases. It is listed on the NASDAQ under the symbol SPECT.
